Literature DB >> 12692050

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome.

L A Houghton1, W Atkinson, R P Whitaker, P J Whorwell, M J Rimmer.   

Abstract

BACKGROUND: Meal ingestion is often associated with exacerbation of gastrointestinal symptoms in subjects with irritable bowel syndrome (IBS). Furthermore, recent preliminary data suggest that 5-hydroxytryptamine (5-HT) concentration in platelet poor plasma is elevated following meal ingestion in some subjects with diarrhoea predominant IBS (d-IBS) compared with healthy subjects, although it is not known whether this is related to postprandial symptomatology. AIM: To expand on previous data by evaluating a larger number of subjects but also to assess plasma 5-hydroxyindole acetic acid (5-HIAA) concentrations, 5-HT turnover, platelet 5-HT stores, and any relationship to symptomatology.
METHODS: We assessed platelet depleted plasma 5-HT and 5-HIAA concentrations for two hours (60 minute intervals) under fasting conditions, and then for a further four hours (30 minute intervals) after a standard carbohydrate meal (457 kcal), together with fasting platelet 5-HT concentrations in 39 female subjects with d-IBS (aged 19-52 years; mean age 33) and 20 healthy female volunteers (aged 20-46 years, mean age 28). IBS symptomatology, in particular abdominal pain and bloating, and urgency to defecate were assessed throughout the study
RESULTS: When related to fasting levels, there was no statistically significant difference in postprandial plasma 5-HT concentrations between d-IBS and healthy subjects. However, when fasting levels were not taken into consideration, d-IBS subjects exhibited higher postprandial plasma 5-HT concentrations compared with healthy subjects (p=0.040). Furthermore, d-IBS subjects who exhibited postprandial symptomatology had higher levels of postprandial plasma 5-HT, whether assessed with respect to fasting baseline levels (p=0.069) or not (p=0.047), compared with d-IBS subjects who did not report postprandial symptomatology. This appeared to be associated with a concomitant increase in plasma 5-HIAA (p=0.161) but reduction in turnover (p=0.058). Lastly, d-IBS subjects had higher platelet concentrations of 5-HT than healthy subjects (p=0.009).
CONCLUSIONS: These data suggest that postprandial symptomatology may be associated with increased platelet depleted plasma 5-HT concentrations in female subjects with d-IBS. In addition, the presence of increased platelet stores of 5-HT may act as a useful marker for the diagnosis and management of d-IBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692050      PMCID: PMC1773651          DOI: 10.1136/gut.52.5.663

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Effects of serotonin on intestinal secretion and motility.

Authors:  Robin C. Spiller
Journal:  Curr Opin Gastroenterol       Date:  2001-03       Impact factor: 3.287

2.  Modification of small bowel mechanosensitivity by intestinal fat.

Authors:  A M Accarino; F Azpiroz; J R Malagelada
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 3.  Disturbances in small bowel motility.

Authors:  E M Quigley
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-10

4.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

5.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome.

Authors:  P Welgan; H Meshkinpour; M Beeler
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

6.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 7.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 8.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  On the accurate determination of serotonin in human plasma.

Authors:  O Beck; N H Wallén; A Bröijersén; P T Larsson; P Hjemdahl
Journal:  Biochem Biophys Res Commun       Date:  1993-10-15       Impact factor: 3.575

10.  Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.

Authors:  F Narducci; G Bassotti; M T Granata; M A Pelli; M Gaburri; R Palumbo; A Morelli
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

View more
  65 in total

1.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

2.  Characteristics of 5-hydroxytryptamine receptors involved in contraction of feline ileal longitudinal smooth muscle.

Authors:  Yiyi Wang; Sun Young Park; Kyung Hoon Oh; Youngsil Min; Yun-Jeong Lee; Seok-Yong Lee; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

3.  Enteroendocrine cells: neglected players in gastrointestinal disorders?

Authors:  Gordon W Moran; Fiona C Leslie; Scott E Levison; J Worthington; John T McLaughlin
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

4.  Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.

Authors:  S Jun; R Kohen; K C Cain; M E Jarrett; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2010-11-12       Impact factor: 3.598

5.  Plasma 5-hydroxytryptamine concentration and its correlation with psychopathology in patients with irritable bowel syndrome.

Authors:  Seon-Young Park; Min-Ho Park; Kyoung-Won Yoon; Sung-Bum Cho; Wan-Sik Lee; Chang-Hwan Park; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

6.  RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio; Asha A Nair; Simon J Gibbons; Gianrico Farrugia; Eric W Klee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

Review 7.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 8.  Diagnosis and treatment of irritable bowel syndrome: state of the art.

Authors:  Kirsten Tillisch; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2005-08

9.  Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.

Authors:  L J Hampson; P Mackin; L Agius
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

10.  Glucose-dependent trafficking of 5-HT3 receptors in rat gastrointestinal vagal afferent neurons.

Authors:  T Babic; A E Troy; S R Fortna; K N Browning
Journal:  Neurogastroenterol Motil       Date:  2012-07-30       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.